ST Germain D J Co. Inc. Purchases 992 Shares of MetLife, Inc. $MET

ST Germain D J Co. Inc. raised its position in shares of MetLife, Inc. (NYSE:MET) by 33.6% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,945 shares of the financial services provider’s stock after purchasing an additional 992 shares during the period. ST Germain D J Co. Inc.’s holdings in MetLife were worth $317,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of MET. Diamond Hill Capital Management Inc. bought a new stake in MetLife during the 1st quarter valued at $336,965,000. Nuveen LLC bought a new stake in MetLife during the 1st quarter valued at $312,946,000. Price T Rowe Associates Inc. MD raised its position in MetLife by 7.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider’s stock valued at $2,126,734,000 after purchasing an additional 1,824,907 shares in the last quarter. Alyeska Investment Group L.P. bought a new stake in MetLife during the 1st quarter valued at $68,030,000. Finally, GAMMA Investing LLC raised its position in MetLife by 8,789.6% during the 1st quarter. GAMMA Investing LLC now owns 815,889 shares of the financial services provider’s stock valued at $65,508,000 after purchasing an additional 806,711 shares in the last quarter. 94.99% of the stock is owned by institutional investors.

MetLife Stock Up 1.7%

Shares of MET stock opened at $81.61 on Friday. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05. The stock’s fifty day moving average price is $78.67 and its 200 day moving average price is $78.14. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market cap of $54.27 billion, a price-to-earnings ratio of 13.83, a price-to-earnings-growth ratio of 0.74 and a beta of 0.87.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing the consensus estimate of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $18.58 billion. During the same quarter last year, the firm earned $2.28 earnings per share. The firm’s quarterly revenue was down 2.7% compared to the same quarter last year. On average, research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th were paid a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a yield of 2.8%. The ex-dividend date was Tuesday, August 5th. MetLife’s payout ratio is presently 38.47%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Cowen reissued a “buy” rating on shares of MetLife in a research report on Friday, August 22nd. JPMorgan Chase & Co. boosted their price target on MetLife from $86.00 to $95.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 8th. Wolfe Research raised MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Piper Sandler lowered MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price target for the company. in a research report on Friday, September 19th. Finally, Morgan Stanley reduced their price target on MetLife from $98.00 to $94.00 and set an “overweight” rating for the company in a research report on Monday, August 18th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $94.64.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.